ELI LILLY & CO (LLY.DE) Stock Fundamental Analysis

FRA:LLY • US5324571083

883.2 EUR
+10.1 (+1.16%)
Last: Feb 13, 2026, 05:29 PM
Fundamental Rating

6

Overall LLY gets a fundamental rating of 6 out of 10. We evaluated LLY against 55 industry peers in the Pharmaceuticals industry. LLY has an excellent profitability rating, but there are some minor concerns on its financial health. LLY is valued quite expensively, but it does show have an excellent growth rating. These ratings would make LLY suitable for growth investing!


Dividend Valuation Growth Profitability Health

8

1. Profitability

1.1 Basic Checks

  • In the past year LLY was profitable.
  • In the past year LLY had a positive cash flow from operations.
  • In the past 5 years LLY has always been profitable.
  • LLY had a positive operating cash flow in 4 of the past 5 years.
LLY.DE Yearly Net Income VS EBIT VS OCF VS FCFLLY.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10B 20B

1.2 Ratios

  • The Return On Assets of LLY (16.02%) is better than 90.91% of its industry peers.
  • LLY's Return On Equity of 77.38% is amongst the best of the industry. LLY outperforms 96.36% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 28.89%, LLY belongs to the top of the industry, outperforming 94.55% of the companies in the same industry.
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROIC 28.89%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
LLY.DE Yearly ROA, ROE, ROICLLY.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100 200 300

1.3 Margins

  • With an excellent Profit Margin value of 30.99%, LLY belongs to the best of the industry, outperforming 96.36% of the companies in the same industry.
  • In the last couple of years the Profit Margin of LLY has grown nicely.
  • LLY's Operating Margin of 44.41% is amongst the best of the industry. LLY outperforms 96.36% of its industry peers.
  • LLY's Operating Margin has improved in the last couple of years.
  • With an excellent Gross Margin value of 83.03%, LLY belongs to the best of the industry, outperforming 87.27% of the companies in the same industry.
  • In the last couple of years the Gross Margin of LLY has remained more or less at the same level.
Industry RankSector Rank
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
LLY.DE Yearly Profit, Operating, Gross MarginsLLY.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40 60 80

5

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so LLY is creating value.
  • LLY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
LLY.DE Yearly Shares OutstandingLLY.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B
LLY.DE Yearly Total Debt VS Total AssetsLLY.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20B 40B 60B

2.2 Solvency

  • LLY has an Altman-Z score of 8.23. This indicates that LLY is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 8.23, LLY belongs to the best of the industry, outperforming 92.73% of the companies in the same industry.
  • The Debt to FCF ratio of LLY is 6.60, which is on the high side as it means it would take LLY, 6.60 years of fcf income to pay off all of its debts.
  • LLY has a Debt to FCF ratio of 6.60. This is comparable to the rest of the industry: LLY outperforms 41.82% of its industry peers.
  • A Debt/Equity ratio of 1.72 is on the high side and indicates that LLY has dependencies on debt financing.
  • With a Debt to Equity ratio value of 1.72, LLY is not doing good in the industry: 80.00% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Altman-Z 8.23
ROIC/WACC3.14
WACC9.21%
LLY.DE Yearly LT Debt VS Equity VS FCFLLY.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B

2.3 Liquidity

  • LLY has a Current Ratio of 1.55. This is a normal value and indicates that LLY is financially healthy and should not expect problems in meeting its short term obligations.
  • The Current ratio of LLY (1.55) is better than 63.64% of its industry peers.
  • A Quick Ratio of 1.24 indicates that LLY should not have too much problems paying its short term obligations.
  • The Quick ratio of LLY (1.24) is better than 72.73% of its industry peers.
Industry RankSector Rank
Current Ratio 1.55
Quick Ratio 1.24
LLY.DE Yearly Current Assets VS Current LiabilitesLLY.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

8

3. Growth

3.1 Past

  • LLY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 86.23%, which is quite impressive.
  • Measured over the past years, LLY shows a very strong growth in Earnings Per Share. The EPS has been growing by 25.01% on average per year.
  • LLY shows a strong growth in Revenue. In the last year, the Revenue has grown by 44.70%.
  • The Revenue has been growing by 21.58% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%

3.2 Future

  • LLY is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 19.21% yearly.
  • The Revenue is expected to grow by 13.06% on average over the next years. This is quite good.
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y19.21%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y13.06%

3.3 Evolution

  • Although the future EPS growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
  • Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.
LLY.DE Yearly Revenue VS EstimatesLLY.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 50B 100B
LLY.DE Yearly EPS VS EstimatesLLY.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 20 40 60

2

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 43.32, which means the current valuation is very expensive for LLY.
  • Compared to the rest of the industry, the Price/Earnings ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 69.09% of the companies listed in the same industry.
  • The average S&P500 Price/Earnings ratio is at 27.67. LLY is valued rather expensively when compared to this.
  • A Price/Forward Earnings ratio of 31.24 indicates a quite expensive valuation of LLY.
  • LLY's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. LLY is more expensive than 69.09% of the companies in the same industry.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 27.69, LLY is valued at the same level.
Industry RankSector Rank
PE 43.32
Fwd PE 31.24
LLY.DE Price Earnings VS Forward Price EarningsLLY.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60

4.2 Price Multiples

  • Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of LLY indicates a slightly more expensive valuation: LLY is more expensive than 69.09% of the companies listed in the same industry.
  • LLY's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. LLY is more expensive than 67.27% of the companies in the same industry.
Industry RankSector Rank
P/FCF 154.04
EV/EBITDA 35.8
LLY.DE Per share dataLLY.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 10 20 30 40 50

4.3 Compensation for Growth

  • LLY's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
  • LLY has an outstanding profitability rating, which may justify a higher PE ratio.
  • A more expensive valuation may be justified as LLY's earnings are expected to grow with 23.44% in the coming years.
PEG (NY)1.12
PEG (5Y)1.73
EPS Next 2Y31.04%
EPS Next 3Y23.44%

4

5. Dividend

5.1 Amount

  • With a yearly dividend of 0.68%, LLY is not a good candidate for dividend investing.
  • LLY's Dividend Yield is comparable with the industry average which is at 1.94.
  • With a Dividend Yield of 0.68, LLY pays less dividend than the S&P500 average, which is at 1.80.
Industry RankSector Rank
Dividend Yield 0.68%

5.2 History

  • On average, the dividend of LLY grows each year by 15.59%, which is quite nice.
Dividend Growth(5Y)15.59%
Div Incr Years6
Div Non Decr Years6
LLY.DE Yearly Dividends per shareLLY.DE Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4 5

5.3 Sustainability

  • LLY pays out 28.28% of its income as dividend. This is a sustainable payout ratio.
  • LLY's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP28.28%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
LLY.DE Yearly Income VS Free CF VS DividendLLY.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 5B 10B 15B 20B
LLY.DE Dividend Payout.LLY.DE Dividend Payout, showing the Payout Ratio.LLY.DE Dividend Payout.PayoutRetained Earnings

ELI LILLY & CO

FRA:LLY (2/13/2026, 5:29:33 PM)

883.2

+10.1 (+1.16%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryPharmaceuticals
Earnings (Last)02-04
Earnings (Next)04-30
Inst Owners83.09%
Inst Owner ChangeN/A
Ins Owners0.16%
Ins Owner ChangeN/A
Market Cap834.96B
Revenue(TTM)65.18B
Net Income(TTM)18.41B
Analysts81.08
Price Target994.71 (12.63%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.68%
Yearly Dividend4.18
Dividend Growth(5Y)15.59%
DP28.28%
Div Incr Years6
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)18.28%
Min EPS beat(2)14.51%
Max EPS beat(2)22.05%
EPS beat(4)4
Avg EPS beat(4)13.1%
Min EPS beat(4)6.45%
Max EPS beat(4)22.05%
EPS beat(8)7
Avg EPS beat(8)12.06%
EPS beat(12)10
Avg EPS beat(12)23.73%
EPS beat(16)13
Avg EPS beat(16)17.41%
Revenue beat(2)2
Avg Revenue beat(2)6.77%
Min Revenue beat(2)4.72%
Max Revenue beat(2)8.81%
Revenue beat(4)2
Avg Revenue beat(4)2.95%
Min Revenue beat(4)-1.24%
Max Revenue beat(4)8.81%
Revenue beat(8)4
Avg Revenue beat(8)2.39%
Revenue beat(12)7
Avg Revenue beat(12)2.64%
Revenue beat(16)9
Avg Revenue beat(16)2.04%
PT rev (1m)5.78%
PT rev (3m)24.88%
EPS NQ rev (1m)-5.7%
EPS NQ rev (3m)-4.57%
EPS NY rev (1m)2.31%
EPS NY rev (3m)7.96%
Revenue NQ rev (1m)0.97%
Revenue NQ rev (3m)1.78%
Revenue NY rev (1m)1.28%
Revenue NY rev (3m)4.59%
Valuation
Industry RankSector Rank
PE 43.32
Fwd PE 31.24
P/S 16.69
P/FCF 154.04
P/OCF 61.72
P/B 41.67
P/tB 86.6
EV/EBITDA 35.8
EPS(TTM)20.39
EY2.31%
EPS(NY)28.27
Fwd EY3.2%
FCF(TTM)5.73
FCFY0.65%
OCF(TTM)14.31
OCFY1.62%
SpS52.93
BVpS21.2
TBVpS10.2
PEG (NY)1.12
PEG (5Y)1.73
Graham Number98.61
Profitability
Industry RankSector Rank
ROA 16.02%
ROE 77.38%
ROCE 35.28%
ROIC 28.89%
ROICexc 33.3%
ROICexgc 41.12%
OM 44.41%
PM (TTM) 30.99%
GM 83.03%
FCFM 10.83%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y16.24%
OM growth 5Y10.3%
PM growth 3Y13.11%
PM growth 5Y4.64%
GM growth 3Y2.65%
GM growth 5Y1.35%
F-Score7
Asset Turnover0.52
Health
Industry RankSector Rank
Debt/Equity 1.72
Debt/FCF 6.6
Debt/EBITDA 1.44
Cap/Depr 507.66%
Cap/Sales 16.2%
Interest Coverage 250
Cash Conversion 56.78%
Profit Quality 34.96%
Current Ratio 1.55
Quick Ratio 1.24
Altman-Z 8.23
F-Score7
WACC9.21%
ROIC/WACC3.14
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)86.23%
EPS 3Y44.11%
EPS 5Y25.01%
EPS Q2Q%41.73%
EPS Next Y38.64%
EPS Next 2Y31.04%
EPS Next 3Y23.44%
EPS Next 5Y19.21%
Revenue 1Y (TTM)44.7%
Revenue growth 3Y31.69%
Revenue growth 5Y21.58%
Sales Q2Q%42.56%
Revenue Next Year21.61%
Revenue Next 2Y19.16%
Revenue Next 3Y15.36%
Revenue Next 5Y13.06%
EBIT growth 1Y82.81%
EBIT growth 3Y53.07%
EBIT growth 5Y34.09%
EBIT Next Year43.42%
EBIT Next 3Y24.82%
EBIT Next 5Y19.97%
FCF growth 1Y382.88%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y166.27%
OCF growth 3YN/A
OCF growth 5YN/A

ELI LILLY & CO / LLY.DE FAQ

Can you provide the ChartMill fundamental rating for ELI LILLY & CO?

ChartMill assigns a fundamental rating of 6 / 10 to LLY.DE.


What is the valuation status of ELI LILLY & CO (LLY.DE) stock?

ChartMill assigns a valuation rating of 2 / 10 to ELI LILLY & CO (LLY.DE). This can be considered as Overvalued.


What is the profitability of LLY stock?

ELI LILLY & CO (LLY.DE) has a profitability rating of 8 / 10.


Can you provide the PE and PB ratios for LLY stock?

The Price/Earnings (PE) ratio for ELI LILLY & CO (LLY.DE) is 43.32 and the Price/Book (PB) ratio is 41.67.


What is the earnings growth outlook for ELI LILLY & CO?

The Earnings per Share (EPS) of ELI LILLY & CO (LLY.DE) is expected to grow by 38.64% in the next year.